Stock Updates

How has Teva Pharmaceutical Industries Limited:(NYSE:TEVA) performed recently?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 50533.91. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 28.52, a forward P/E of 9.14 and EPS of 1.92. At a stock price of 53.78 (-1.85%) it has a dividend yield of 2.48%.

EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 13.12% and more long-term 5.23% after five years. EPS growth quarter over quarter is 19.10%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is -3.50%.

For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of 0.29%. For the last month performance for Teva Pharmaceutical Industries Limited is 10.53%. While the last quarter is 0.30% and half year, -8.15%. Finally for the year, performance is -20.87%.

The 52-week high for Teva Pharmaceutical Industries Limited, is at -23.31%, and for the 52-week low it comes to a value of 12.01%. The 20-day simple moving average is 2.57% and -5.48% for the 200-day simple moving average.

Volatility for the week is at 1.43%, and for the month it is 1.87%. Teva Pharmaceutical Industries Limited, has a target price of 71.05.

In terms of debt, long term debt/equity is 0.28, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.34. The gross margin is 58.10%, while operating margin is 19.30%, the profit margin is 8.70%. The current ratio is 1.3 and the quick ratio is 1.

Insider ownership is at 2.70%, with instituitional ownership at 65.80%. Teva Pharmaceutical Industries Limited has a payout ratio of 70.10%. With the total shares outstanding coming to 922.32. The shares float is 914.06, with the float short at 2.18%, with short ratio coming to 3.21.

In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 3.30%, with its returns on investment at 5.70%. Return on equity is 6.60%. So will the investors see the target price of 71.05, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment